Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Europe GmbH

Inauguration of New Building – Investment in Our Pfaffenhofen Plant

Plant Expansion: New Building for Our Pharmaceutical Development Team in Pfaffenhofen, Germany

Pfaffenhofen in Southern Germany is the hometown of our biggest production and development site outside of Japan. At the beginning of November 2014 a new building was inaugurated here in Bavaria. The modern annexe – a 13 million investment – provides our Pharmaceutical Development Team with a new and state of the art working environment.

Pharmaceutical Products „Made in Germany“ for 50 countries

At Pfaffenhofen we manufacture about 3 billion tablets per year for 50 countries. But not only production but also pharmaceutical development is gaining in importance for our colleagues in Pfaffenhofen. Nora Urbanetz, Ph.D., leads the team responsible for the development of compounds into innovative products. She regards the substantial investment of 13 million Euros by our Japanese parent company as a sign of confidence in her team’s work. More compounds are transferred to Germany at an early stage for further pharmaceutical development. In Pfaffenhofen they are turned into products which are then tested in clinical trials before they can be approved by regulatory bodies and are ready for the manufacturing stage.